As of Jun 26, 2025, the USNA stock has a PE ratio of 16.87. The calculation is based on the latest EPS of $1.83 and the stock price of $30.87 per share. An increase of 12% has been observed in the PE ratio compared to its average of 15.1 of the last four quarters.
The mean historical PE ratio of Usana Health Sciences over the last ten years is 17.59. The current 16.87 P/E ratio is 4.1% lower than the historical average. Looking back at the last ten years, USNA's PE ratio peaked in the Jun 2018 quarter at 34.42, with a price of $115.3 and an EPS of $3.35. The Mar 2020 quarter marked the lowest point at 12.76, with a price of $59.35 and an EPS of $4.65.
Maximum annual increase: 94.93% in 2013
Maximum annual decrease: -37.75% in 2011
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 16.22 | 0.19% | $35.69 | $2.2 |
2023 | 16.19 | 9.54% | $53.6 | $3.31 |
2022 | 14.78 | -15.59% | $53.2 | $3.6 |
2022 | 17.51 | 33.77% | $101.2 | $5.78 |
2021 | 13.09 | -27.36% | $77.1 | $5.89 |
2019 | 18.02 | -17.87% | $80 | $4.44 |
2018 | 21.94 | -23.85% | $114.96 | $5.24 |
2017 | 28.81 | 94.93% | $74.05 | $2.57 |
2016 | 14.78 | -13.92% | $61.2 | $4.14 |
2016 | 17.17 | -2.61% | $63.88 | $3.72 |
2015 | 17.63 | 31.08% | $51.14 | $2.9 |
2013 | 13.45 | 94.93% | $38.86 | $2.89 |
2012 | 6.9 | -25% | $15.8 | $2.29 |
2011 | 9.2 | -37.75% | $15.19 | $1.65 |
2011 | 14.78 | 1.93% | $21.73 | $1.47 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 15.18 | -6.41% | $27.78 | $1.83 |
Dec 2024 | 16.22 | 21.5% | $35.69 | $2.2 |
Sep 2024 | 13.35 | -15.29% | $37.92 | $2.84 |
Jun 2024 | 15.76 | 4.3% | $45.24 | $2.87 |
Mar 2024 | 15.11 | -6.67% | $48.5 | $3.21 |
Dec 2023 | 16.19 | -14.65% | $53.6 | $3.31 |
Sep 2023 | 18.97 | -1.3% | $58.61 | $3.09 |
Jul 2023 | 19.22 | 3.61% | $63.04 | $3.28 |
Apr 2023 | 18.55 | 25.51% | $62.9 | $3.39 |
Dec 2022 | 14.78 | 5.5% | $53.2 | $3.6 |
Oct 2022 | 14.01 | -14.26% | $56.05 | $4 |
Jul 2022 | 16.34 | 12.85% | $75 | $4.59 |
Apr 2022 | 14.48 | -17.3% | $79.33 | $5.48 |
Jan 2022 | 17.51 | 23.66% | $101.2 | $5.78 |
Oct 2021 | 14.16 | -7.21% | $93.58 | $6.61 |
The current PE ratio of USNA is higher than its 3 and 5-year averages, but it is lower than its 10-year average.
USNA's PE ratio stands lower than its peer stocks IPAR and NATR, but it is higher than HLF's.
Stock name | PE ratio | Market cap |
---|---|---|
HLF Herbalife Nutrition Ltd | 3.03 | $859.59M |
USNA Usana Health Sciences Inc | 17.02 | $579.92M |
IPAR Inter Parfums Inc | 25.61 | $4.25B |
NATR Natures Sunshine Products Inc | 26.35 | $265.9M |
NUS Nu Skin Enterprises Inc | N/A | $398.27M |
PRPH ProPhase Labs Inc | N/A | $15.64M |
MTEX Mannatech Inc | N/A | $18.44M |
The price to earnings ratio for USNA stock as of Jun 26, 2025, stands at 16.87.
The average PE ratio for USNA stock over the past 3 years is 16.14.
The average PE ratio for USNA stock over the past 5 years is 15.69.
Over the last ten years, the Jun 2018 quarter recorded the highest quarterly PE ratio at 34.42.
USNA's current price to earnings ratio is 4.1% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 26, 2025), Usana Health Sciences's share price is $30.87. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.83. Therefore, Usana Health Sciences's PE ratio for today is 16.87. PE RATIO(16.87) = STOCK PRICE($30.87) / TTM EPS($1.83)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.